ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 573,31
-0,78%
Dow Jones
40 211,72
0,53%
DAX
18 506,77
-0,50%
Brent Oil
83,085
-1,49%
Bitcoin
63 697,39
-1,78%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
22/04/202114h00PR Newswire (US)Insmed to Host First Quarter 2021 Financial Results Conference Call on Thursday, May 6, 2021NASDAQ:INSMInsmed Inc
12/04/202119h07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
07/04/202114h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
01/04/202122h30Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
29/03/202119h26Edgar (US Regulatory)Sec Staff Action/letter (sec Staff)NASDAQ:INSMInsmed Inc
23/03/202110h00PR Newswire (US)ARIKAYCE® (amikacin liposome inhalation suspension) Approved by Japan's Ministry of Health, Labour and Welfare for the Treat...NASDAQ:INSMInsmed Inc
18/03/202121h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
25/02/202114h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
25/02/202113h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
24/02/202114h00PR Newswire (US)Insmed to Present at Two March ConferencesNASDAQ:INSMInsmed Inc
19/02/202113h30PR Newswire (US)Insmed Announces Topline Results from Phase 1 Study of Treprostinil Palmitil Inhalation Powder (TPIP)NASDAQ:INSMInsmed Inc
16/02/202114h00PR Newswire (US)Insmed to Host Conference Call to Discuss Topline Data from Treprostinil Palmitil Inhalation Powder Phase 1 StudyNASDAQ:INSMInsmed Inc
12/02/202114h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021NASDAQ:INSMInsmed Inc
05/01/202114h00PR Newswire (US)Insmed to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
04/01/202114h00PR Newswire (US)Insmed Initiates Frontline Clinical Trial Program for ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with M...NASDAQ:INSMInsmed Inc
02/12/202014h00PR Newswire (US)Insmed Announces Initiation of Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
24/11/202014h00PR Newswire (US)Insmed to Present at the Evercore ISI 3rd Annual HealthCONx ConferenceNASDAQ:INSMInsmed Inc
13/11/202014h00PR Newswire (US)Insmed Receives Priority Medicines (PRIME) Designation from European Medicines Agency (EMA) for Brensocatib in Patients with ...NASDAQ:INSMInsmed Inc
02/11/202014h00PR Newswire (US)Insmed to Present at Two November ConferencesNASDAQ:INSMInsmed Inc
29/10/202012h30Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
29/10/202012h30PR Newswire (US)Insmed Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
28/10/202012h37PR Newswire (US)European Commission Grants Marketing Authorization for ARIKAYCE® Liposomal 590 mg Nebuliser Dispersion for the Treatment of ...NASDAQ:INSMInsmed Inc
20/10/202014h00PR Newswire (US)Insmed to Host Third Quarter 2020 Financial Results Conference Call on Thursday, October 29, 2020NASDAQ:INSMInsmed Inc
30/09/202014h00PR Newswire (US)Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D DayNASDAQ:INSMInsmed Inc
16/09/202014h00PR Newswire (US)Insmed to Host R&D Day on September 30, 2020NASDAQ:INSMInsmed Inc
09/09/202022h05PR Newswire (US)Insmed to Present at Three September ConferencesNASDAQ:INSMInsmed Inc
07/09/202017h24PR Newswire (US)New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cyst...NASDAQ:INSMInsmed Inc
06/08/202013h30PR Newswire (US)Insmed Reports Second Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
27/07/202014h00PR Newswire (US)Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020NASDAQ:INSMInsmed Inc
24/07/202013h39PR Newswire (US)Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect...NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
VIV
Vivendi
EU
CAP
Capgemini
EU
PX1
CAC 40
USI
USTECH100
US Tech 100
EU
DG
Vinci
EU
RI
Pernod Ricard
EU
CS
Axa
NASDAQ
MSFT
Microsoft
SPI
SP500
S&P 500
NYSE
MRK
Merck
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
EN
Bouygues
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés